BioSpace News Archive

Krystal Biotech, Inc. announced today the appointments of Jing Marantz as Chief Business Officer and Rand Sutherland as a new member of the Board of Directors.

Sema4, an AI-driven genomic and clinical data intelligence platform company, and OPKO Health, Inc., a multinational biopharmaceutical and diagnostics company, announced they have signed a definitive agreement for Sema4 to acquire OPKO’s wholly owned subsidiary, GeneDx, Inc., a leader in genomic testing and analysis, from OPKO.

Stellar modules set a new standard for western blotting fluorescence detection sensitivity.

BioLineRx Ltd. today announced that the Company has completed a successful pre-New Drug Application (NDA) meeting with the US Food and Drug Administration (FDA).

Alkermes plc announced plans to present a poster related to nemvaleukin alfa, the company’s novel, investigational, engineered interleukin-2 variant immunotherapy, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium, taking place Jan. 20-22, 2022.

Diadem U.S., Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for AlzoSure® Predict.

CASI Pharmaceuticals, Inc. announced today, that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its partner Juventas Cell Therapy LTD.

CytoSorbents Corporation issues a stockholder letter from its Chief Executive Officer, Dr. Phillip Chan, and announces preliminary unaudited fourth quarter 2021 and full year 2021 results ahead of filing its Form 10-K.

Endo Tools Therapeutics (ETT), today announces the U.S. Food and Drug Administration (FDA) 510(k) clearance of the endomina® system, designed for endoscopic placement of suture(s) and approximation of soft tissue in the gastrointestinal tract on adult population.

Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has entered into a definitive agreement to acquire Pack Health in an all-cash equity transaction.